DBT and cholangiocarcinoma: Dihydrolipoamide Branched Chain Transacylase E2(DBT) catalyzed α-keto acid to acyl-CoA, which is thought to be associated with protective effects in both LUAD and cervical cancer(CC) patients [159, 164].